BRIEF-FDA grants fast track designation for Medicinova's drug for progressive multiple sclerosis

* FDA grants fast track designation for Medicinova's MN-166

(ibudilast) for progressive multiple sclerosis

Source text for Eikon:

Further company coverage:

Read more